Oryzon Genomics SA's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Oryzon Genomics SA is scheduled to report earnings on May 3, 2024, and the estimated EPS forecast is €-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Jun 21
Income Statement	-
Total Revenue	€ 0.00	€ 0.00	€ 0.00	€ 0.00	€ 0.00
Gross Profit	-	-	-	-	€ 1.73M
EBIT	€ 9.99M	€ -4.93M	€ 1.81M	€ -5.57M	€ -1.57M
EBITDA	€ 9.99M	€ -4.93M	€ 1.81M	€ -5.57M	€ -1.53M
Net Income Common Stockholders	€ -2.32M	€ -618.00K	€ 325.08K	€ -1.81M	€ 800.92K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 21.32M	€ 27.08M	€ 22.72M	€ 28.03M	€ 33.73M
Total Assets	€ 103.70M	€ 103.16M	€ 96.34M	€ 103.46M	€ 95.28M
Total Debt	€ 17.44M	€ 0.00	€ 14.45M	€ 0.00	€ 11.37M
Net Debt	€ -3.88M	€ -27.08M	€ -8.26M	€ -28.03M	€ -22.35M
Total Liabilities	€ 31.13M	€ 33.91M	€ 26.22M	€ 26.17M	€ 20.35M
Stockholders Equity	€ 72.57M	€ 69.25M	€ 70.12M	€ 77.30M	€ 74.93M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in EUR

Oryzon Genomics SA Earnings and Revenue History

Income Statement >

Oryzon Genomics SA Debt to Assets

Balance Sheet >

Oryzon Genomics SA Cash Flow

Cash Flow >

Oryzon Genomics SA Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing